Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare...

Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on
Healthcare Conference

MOUNTAIN VIEW, Calif., July 31 /PRNewswire/ -- Cardiva Medical, Inc., a
privately held medical device company, announced today that Augustine Lien,
Chairman and CEO, will present at the BMO Capital Markets 2008 Focus on
Healthcare conference on Tuesday, August 5 at 1:15 p.m. EDT at the Millennium
Broadway Hotel in New York City. Mr. Lien's presentation will include an
overview of the Company's current operations and growth strategy.
Details of the presentation follow:
Date: Tuesday, August 5, 2008
Time: 1:15 p.m. (EDT)
Location: The Millennium Broadway Hotel
Speaker: Augustine Lien, Chairman and CEO

About Cardiva Medical, Inc.
Founded in July 2002, and headquartered in Mountain View, Calif., Cardiva
Medical, Inc. is a privately held medical device company focused on developing
and commercializing devices which close the vascular access site with
unsurpassed safety and ease-of-use. Cardiva's first product, the Boomerang
Wire System, was approved in EU countries and in the U.S. in 2004. Cardiva's
second-generation product, the Boomerang Catalyst System, was approved in
March 2007 and launched in July 2007. The enhanced Boomerang Catalyst, trade
named as "Boomerang Catalyst II System" received 510(K) clearance in September
2007 and launched in January 2008. To date, the family of Boomerang and
Boomerang Catalyst devices has been used in 150,000 percutaneous
catheterization procedures in the U.S. Cardiva was selected by Frost &
Sullivan as the recipient of the 2006 Frost & Sullivan Award for
Entrepreneurial Company in the U.S. angioplasty and vascular closure devices
market. For additional information about Cardiva please see our website at
http://www.cardivamedical.com.
Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimated" and "intend," among others.
These forward-looking statements are based on Cardiva's current expectations
and actual results could differ materially. Cardiva does not undertake an
obligation to update or revise any forward-looking statement. Cardiva,
Boomerang and Boomerang Catalyst System are trademarks/registered trademarks
of Cardiva Medical, Inc.
Media Contact:
Glenn Foy, President
Cardiva Medical, Inc.
Phone: 650.475.9850
Fax: 650.964.8911
glenn_foy@cardivamedical.com

SOURCE Cardiva Medical, Inc.

Glenn Foy, President of Cardiva Medical, Inc., +1-650-475-9850, fax,
+1-650-964-8911, glenn_foy@cardivamedical.com